- By Mary MacDonald
- Email the author
- November 30, 2012
- State Sen. Richard Moore, who represents the Milford area, will serve on a
state panel that will make recommendations on regulations for compounding
pharmacies.The Special Commission on Compounding Pharmacies was created following a deadly outbreak of fungal meningitis, linked to the New England Compounding Center in Framingham.
The 10-member commission will review best practices in other states for regulations of compounding pharmacies that create injectible medications, according to a press release. It will make recommendations on proposed regulations or amendments to state or federal laws to protect consumers.
According to national health officials, 36 people have died related to the meningitis outbreak. Framingham specialty pharmacy New England Compounding Center (NECC) has been linked to the deadly outbreak.
Another 510 individuals are affected, infected with meningitis in 19 states. All of the NECC products have been recalled and the company has been shut down.
Source found here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, December 1, 2012
Meningitis outbreak: Cases moved from state to federal court
4:46 PM, Nov 30, 2012
Lawyers for the drug compounding firm
blamed for a deadly nationwide outbreak of fungal meningitis are moving forward
with a strategy to get the growing number of lawsuits consolidated in federal
court and want a Boston-based judge to preside over all of them.
Federal court records show that a total of
37 cases originally filed in state and county courts have been transferred to
federal courts across the country at the request of lawyers representing the New
England Compounding Center. The lawyer for the company, headquartered in
suburban Framingham, says it wants the cases eventually to be consolidated in
Massachusetts.
That would include six suits originally
filed in circuit court in Nashville and subsequently transferred to U.S.
District Court here.
Forty other cases against the company were
filed in federal courts to begin with, pushing the total number of pending
federal suits over 70. Dozens of additional suits still remain in local courts,
including seven in Davidson Circuit Court. Lawyers for the compounding firm have
predicted that the final total will top 400.
In several of the transferred cases, New
England Compounding’s lawyers have stated that their ultimate goal is to have
all of the cases consolidated in Boston before U.S. District Judge F. Dennis
Saylor IV, who currently has a dozen cases assigned to him.
“Judge Saylor has the judicial experience
needed to steer this anticipated massive litigation on a prudent course to an
expeditious conclusion,” New England’s attorney wrote in a recently filed
brief.
“That’s what their plan is,” said
Nashville attorney Randy Kinnard, who represents Colette Rybinski of Smyrna, the
widow of Thomas W. Rybinski , who was the first patient to be diagnosed with
fungal meningitis. He also represents nine other victims.
Continue reading here
Continue reading here
In wake of meningitis outbreak, Dana-Farber Cancer Institute explains compounding
11/28/2012 3:01
Hundreds of fungal infections linked to injectable drugs made by a Framingham specialty pharmacy have sparked questions among regulators, hospitals, and patients about the role such drugmakers play in providing crucial drugs.
In an effort to educate patients about its drug compounding efforts, Dana-Farber Cancer Institute has produced a video that goes into its pharmacy, showing how drugs are prepared and what steps the hospital takes to ensure that drugs are safe and sterile. Compounding is a little-known corner of pharmacy that involves preparing individualized doses for patients, but the company at the center of a major public health crisis, New England Compounding Center, was apparently acting more like a drug manufacturer, providing large batches of drugs and shipping them nationally.
Dana-Farber’s compounding pharmacy prepares 950 sterile products a day, including chemotherapy, anti-nausea medication, and intravenous
Continue reading here
By Carolyn Y. Johnson, Globe Staff
Hundreds of fungal infections linked to injectable drugs made by a Framingham specialty pharmacy have sparked questions among regulators, hospitals, and patients about the role such drugmakers play in providing crucial drugs.
In an effort to educate patients about its drug compounding efforts, Dana-Farber Cancer Institute has produced a video that goes into its pharmacy, showing how drugs are prepared and what steps the hospital takes to ensure that drugs are safe and sterile. Compounding is a little-known corner of pharmacy that involves preparing individualized doses for patients, but the company at the center of a major public health crisis, New England Compounding Center, was apparently acting more like a drug manufacturer, providing large batches of drugs and shipping them nationally.
Dana-Farber’s compounding pharmacy prepares 950 sterile products a day, including chemotherapy, anti-nausea medication, and intravenous
Continue reading here
Subscribe to:
Posts (Atom)